ABSTRACT As global populations age, cancer is increasingly becoming a leading cause of morbidity and mortality among older adults, particularly in low‐ and middle‐income countries (LMICs). Despite accounting for the majority of new cancer cases and deaths, older individuals remain underrepresented in cancer research, clinical guidelines, and health ...
Ibrahim Bidemi Abdullateef +2 more
wiley +1 more source
Working in the profit versus not for profit sector: what difference does it make? An inquiry on preferences of voluntary and involuntary movers [PDF]
We investigate what is behind the profit/not for profit wage differential by comparing judgments on job caracteristics of workers who voluntarily or involuntarily moved from the first to the second sector. We define voluntary movers those who applied for
Leonardo Becchetti +2 more
core
Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin +2 more
wiley +1 more source
Possibilities of implementing the performance management process of non-profit organizations to the defence system [PDF]
Radiša Saković +2 more
openalex +1 more source
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela +13 more
wiley +1 more source
(Mis)taking social responsibility? Implementing welfare state reform by private and non-profit organizations [PDF]
Nicolette van Gestel +2 more
openalex +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
Competition as an Effective Tool in Developing Social Marketing Programs: Driving Behavior Change through Online Activities [PDF]
Nowadays, social marketing practices represent an important part of people’s lives. Consumers’ understanding of the need for change has become the top priority for social organizations worldwide.
Corina SERBAN
core
Corporate social responsibility in non-profit organizations
Guillaume Plaisance
openalex +1 more source

